Vibrational spectroscopy identifies myocardial chemical modifications in heart failure with preserved ejection fraction

J Transl Med. 2023 Sep 11;21(1):617. doi: 10.1186/s12967-023-04465-0.

Abstract

Background: Vibrational spectroscopy can be a valuable tool to monitor the markers of cardiovascular diseases. In the present work, we explored the vibrational spectroscopy characteristics of the cardiac tissue in an experimental model of heart failure with preserved ejection fraction (HFpEF). The goal was to detect early cardiac chemical modifications associated with the development of HFpEF.

Methods: We used the Fourier-transform infrared (FTIR) and Raman micro-spectroscopic techniques to provide complementary and objective tools for the histological assessment of heart tissues from an animal model of HFpEF. A new sampling technique was adopted (tissue print on a CaF2 disk) to characterize the extracellular matrix.

Results: Several spectroscopic markers (lipids, carbohydrates, and glutamate bands) were recognized in the cardiac ventricles due to the comorbidities associated with the pathology, such as obesity and diabetes. Besides, abnormal collagen cross-linking and a decrease in tryptophan content were observed and related to the stiffening of ventricles and to the inflammatory state which is a favourable condition for HFpEF.

Conclusions: By the analyses of tissues and tissue prints, FTIR and Raman techniques were shown to be highly sensitive and selective in detecting changes in the chemistry of the heart in experimental HFpEF and its related comorbidities. Vibrational spectroscopy is a new approach that can identify novel biomarkers for early detection of HFpEF.

Keywords: FTIR imaging; HFpEF; Heart tissue; Micro-Raman spectroscopy; Tissue print.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Heart
  • Heart Failure*
  • Myocardium
  • Spectrum Analysis
  • Stroke Volume